Business   

Tatas pick up equity stake in Indigene Pharma

Special Correspondent

Indigene set to launch four products in the U.S. initially

MUMBAI: Indigene Pharmaceuticals (Indigene) and Tata Industries Limited (TIL) announced on Friday that they have entered into a strategic alliance and that TIL has taken a "significant'' equity stake in Indigene. Indigene, a rapidly growing biopharmaceutical company with its operations in Boston (U.S.), Europe and India, is focused on developing and delivering molecular combination-based products for global prescription and consumer healthcare markets.

TIL is a Tata group company that manages the group's new initiatives and promoted companies.

Product development

Speaking on the occasion, Ratan N. Tata, Chairman, TIL, said, "Biotechnology and biopharmaceutical areas offer great potential in creating value and improving the quality of life for people around the world. We see a bright future in the pharmaceutical industry and Indigene, with its unique approach to product development, technology and a highly reputed global team, is well equipped to meet the challenges of the future.'' Founded by M. Vaman Rao in 2002, Indigene Pharmaceuticals has rapidly developed into a new-age pharma company with a strategic focus on innovative, safe and effective molecular combination-based products for both prescription (Rx) and consumer healthcare (CHC) markets.

Indigene is set to launch four CHC products in large self-medication areas in the U.S. initially followed by India and other geographies.

Indigene has established an alliance with the Council of Scientific and Industrial Research (CSIR) for developing leads in select disease areas. R. A. Mashelkar, Director General, CSIR, and Secretary, Department of Scientific and Industrial Research (DSIR), called for new-age pharma approach.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Panel for open sky policy on mineral prospecting
Centre receives 54 bids for coal bed methane blocks in third round
Hutchison buys Hinduja stake in cellular JV
Sun Group buys stake in Russian gas firm
Sensex vaults 447 points
Tatas pick up equity stake in Indigene Pharma
Rupee gains 24 paise
Bayer Material to set up unit in Greater Noida
Exchange rates
Bullion rates
Shirdi Industries enters capital market
Wyeth launches vaccine for infants
Bajaj Allianz launches 7 unit linked insurance plans
United Bank selects HP and Infosys for IT deal
Central Bank to distribute UTI MF products
Creative Mobus introduces Home Expressions
Nucleus Software system for Cholamandalam
Nine part-time directors for BEL
Thomas Cook to merge LKP Forex
ACC completes sale of Mancherial Cement Works
Jan Verplancke joins Cambridge Solutions' board
Deadline extended for investment u/s 54EC
Inflation rate surges to 5.44 p.c.
Fed raises rate
O. P. Bhat is new SBI Chairman
Base price for crude palm oil raised
Forex reserves dip $1.073 b
One-point rise in Consumer Price Index

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu